bharat biotech
-
Stories
India’s first intranasal vaccine iNCOVACC has been launched in Hyderabad
The center launched India’s first nasal covid-19 vaccine on Thursday. The vaccine was named iNCOVACC and launched in Hyderabad by…
Read More » -
Stories
Bharat Biotech Cruel Joke Hasn’t Paid Off. Why Covaxin is Expensive; Amid Claims of the Covid-19 Vaccine Being Cheaper than A Water Bottle?
The Covid-19 vaccine scenario in India is an utter shame on the government and the pharmaceutical companies. While millions are…
Read More » -
Trends
Bharat Biotech To Increase The Production Of Covaxin: Now 200 Million Additional Vaccine Doses Per Year
Vaccines have become very much crucial during the COVID-19 era. The virus is mutating and is becoming more powerful and…
Read More » -
Stories
Covid-19 Second Wave: The egotism of the BJP Politicians hasn’t served well for the nation
Arrogance doesn’t comprehend well when the citizens are suffering from the tragic catastrophic of Covid-19. We have become used to…
Read More » -
Stories
The 1,500-mile travel itinerary of a coronavirus vaccine to reach every part of India
India is fighting the world’s fastest-growing outbreak of diseases while also implementing one of the most logistically complex vaccination campaigns.…
Read More » -
Stories
Will your state government be able to provide a vaccine for your safety now?
The National Vaccine Administration Expert Group (NEGVAC) was formed for the first time on 20 August last year. The Commission…
Read More » -
Stories
As India Completes Its 1st Dry Run Vaccination, Bharat Biotech’s COVAXIN And Serum Institute’s COVISHIELD Gets Approval for Emergency Use
As India Completes Its First Dry Run Vaccination, Bharat Biotech’s COVAXIN And Serum Institute’s COVISHIELD Gets Approval for Emergency Use…
Read More » -
Stories
Coronavirus Vaccine Update: Frontline Laborers, MBBS Understudies To Get Inoculation First, Any Administration Personal ID Can Be Utilized
As Bharat Biotech is planning to dispatch its antibody — Covaxin — in February, which could be the first immunization…
Read More » -
Stories
Third phase human trial of COVID-19 vaccine to commence in Bhubaneswar soon
The third phase of the human trial of the indigenous vaccine against COVID-19, COVAXIN, will commence at a private hospital…
Read More » -
Trends
Is Oxford University’s new COVID-19 vaccine safe?
The much-anticipated outcome of Phase I/II preliminaries of the Oxford University’s vaccine candidate ‘AZD1222’ has quite recently been released and…
Read More »